drugset

drugset / Trial / NCT00190619

Efficacy and Safety of Duloxetine

NCT00190619 ↗

Phase 3 Completed 100 enrolled Eli Lilly and Company Boehringer Ingelheim · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to monitor the long term safety and efficacy of duloxetine in the treatment of severe pure genuine stress incontinence.

Timeline

Start: 2001-05
Primary completion: —
Completion: 2006-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Duloxetine	Small molecule	—	—

Indications